Thursday, September 17, 2026

Who Knows, Whose Nose, Needs Mohs*

 


Setting of House Call

 

I retired from my dermatology practice ~ six months ago. 

A few days ago, T.G.,  an old patient, called me regarding his visit with his new dermatologist who practices in our area. She is a “Mohs” surgeon, but not  Fellowship trained being a member of the American Society of Mohs Surgeons (https://www.mohssurgery.org/). She found a basal cell carcinoma on his nose. The patient is a worrier and he, nor his wife) had ever even noticed this lesion. A biopsy showed basal cell carcinoma, so she brought him in for surgery. He is a 75-year-old man in excellent health (I have known him for almost 20 years), although he does have significant health anxiety. The “Mohs’ surgeon did not give him options such as radiotherapy, which is closer to his home. Instead, she brought him in for Mohs. It took three stages and he wound up with a graft from near his left ear. It’s clear that this may have been over-treatment. I asked him to get the path reports for me. The point here is overuse of Mohs surgery in the United States. We have over 2400 Mohs surgeons. Canada has around 30. About half of the Mohs surgeons in the US are not Fellowship trained. Doug Johnson and I have been trying to research this. The question is how to protect patients from venal Mohs surgeons and educate them better. Of course, I need to make sure that this patient did not have an infiltrative basal cell. If that was so micrographic surgery was appropriate, but the fellowship trained Mohs surgeons did not have the background to do it properly. 

Two days later I drove up to Vermont to do a house call on T.G.. He had a copy of the path report which  showed that a shave biopsy showed a small modular basal cell carcinoma on the left ala nasi. The dermatologist made a follow up appointment for micrographic surgery. The lesion was tiny, less than 6 mm in diameter. He was given no other options such as observation, imiquimod or radiotherapy. The dermatologist is not fellowship trained, but is a member of the American Society for Micrographic Surgery. I checked the wound (Figure 1).


It appears that the tumor was a small lesion and is now covered with a bolster. While I think this therapy is appropriate, it also could be excessive. My main criticism is that he was not given any options. He lives about 2 miles from a hospital that has good radiotherapy. The micrographic surgeon is about 30 miles from his home. In my opinion, there are obvious problems with Mohs surgeons who do not have the appropriate training, but can legally call themselves Mohs surgeons. 

While I was at the patient’s house, he asked if I would mind seeing his son. His son who is about 50 years old has no medical insurance.  Shortly thereafter, he came over the house. He has what appears to be an ulcerative basal cell carcinoma on the left lower lid (Figure 2). 

Ironically, this lesion would be appropriate for micrographic surgery, but it require a diagnostic biopsy. Getting treatment for a lesion such as this which would require micrographic surgery and possibly oculoplastic repair or radiotherapy (although he is on the young side).  Both would be expensive propositions for a patient without insurance.

* Who knows/ whose nose/ needs Mohs. is a poem written by E. Dorinda Shelly

Wednesday, September 2, 2026

Dr. Paul S. Russell, Obituary

 Dr. Paul S. Russell, who was born before the discovery of penicillin and who became a leading transplant surgeon, adapting scientific breakthroughs in the laboratory to help make the miracle of a new kidney or liver a relatively common procedure, died on Aug. 22 at his home in Westwood, Mass. He was 101.

His long tenure at Massachusetts General led to vast improvements at the hospital in organ transplant care. In the late 1960s, he also created an organ bank to match donors to recipients.

If you can't access the NY Times Obit, and want to read the full article, please email DJ Elpern and I'll send you a link. 

Image from MGH Archives


Between a Rock and a Hard Place

The patient is a 53-year-old man with a two-year history of lesion on the left lower lid. He had a basal cell carcinoma of the left ala that...